Can we finally outsmart recurrent yeast infections? a new study investigates
NCT ID NCT06397248
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This study aims to understand why some women get recurrent vaginal yeast infections (vulvovaginal candidiasis) and others don't. Researchers will compare the vaginal microbiome, immune markers, and metabolic profiles of women with and without the infection. By identifying key differences, they hope to pave the way for better diagnostic tools and treatments. The study will involve 300 women, half with the infection and half without.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could identify biomarkers and therapeutic targets for vulvovaginal candidiasis, potentially leading to more effective diagnosis and treatment options.
- What could go wrong
- This is an observational study, so it cannot prove cause and effect. The findings may not translate into new treatments, and the complexity of the vaginal ecosystem could limit the applicability of the results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VULVOVAGINAL CANDIDIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Antwerp (UZA)
Edegem, Antwerpen, 2650, Belgium
-
University of Antwerp
Antwerp, Antwerpen, 2020, Belgium
-
University of Antwerp
Antwerp, Antwerp, 2020, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.